1.75
-0.11(-5.91%)
Currency In USD
| Previous Close | 1.86 |
| Open | 1.85 |
| Day High | 1.91 |
| Day Low | 1.75 |
| 52-Week High | 36 |
| 52-Week Low | 1.41 |
| Volume | 29,596 |
| Average Volume | 487,502 |
| Market Cap | 2.58M |
| PE | -0.04 |
| EPS | -48.2 |
| Moving Average 50 Days | 3.58 |
| Moving Average 200 Days | 7.71 |
| Change | -0.11 |
If you invested $1000 in 60 Degrees Pharmaceuticals, Inc. (SXTP) since IPO date, it would be worth $6.45 as of March 13, 2025 at a share price of $1.81. Whereas If you bought $1000 worth of 60 Degrees Pharmaceuticals, Inc. (SXTP) shares 1 year ago, it would be worth $114.12 as of March 13, 2025 at a share price of $1.81.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split
GlobeNewswire Inc.
Feb 20, 2025 3:36 PM GMT
WASHINGTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
GlobeNewswire Inc.
Feb 11, 2025 5:59 PM GMT
WASHINGTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical company today announced that the United States Food and Drug Administration (FDA) does not object t
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Feb 06, 2025 7:07 PM GMT
Raised approximately $2.118 million in gross proceeds since the beginning of 2025WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing ne